Skip to content

Use of Fish Skin Graft (FSG) to Improve Wound Healing and Expedite Discharge at a County Safety-net Hospital

Use of Fish Skin Graft (FSG) to Improve Wound Healing and Expedite Discharge at a County Safety-net Hospital

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06910189
Enrollment
96
Registered
2025-04-04
Start date
2025-04-15
Completion date
2026-11-30
Last updated
2025-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgical Wound

Keywords

Fish Skin Graft (FSG), Kerecis

Brief summary

The purpose of this study is to estimate the effect of FSG (Kerecis) on hospital length of stay among adult patients with surgical wounds of at least 40cm2 requiring surgical debridement

Interventions

DEVICEFish Skin Graft (FSG)

FSG will be applied to the wound bed, followed by a wound VAC at the time of surgical debridement

DEVICEWound Vacuum-Assisted Closure (VAC)

Participants will have a wound VAC applied to their wound bed at the time of surgical debridement.

Sponsors

The University of Texas Health Science Center, Houston
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Masking description

Patients and nursing staff will be blinded to the patient's study arm. The operative physician will not be blinded

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Has wound greater than or equal to 40cm2 requiring surgical debridement * Agreeable to follow up period of up to 1 year

Exclusion criteria

* Patients with wounds that do not require surgical debridement. * Patients with a known allergy or other sensitivity to fish material * Patients who are deemed unlikely to follow up (e.g., patients who live out of state). * Patients in police custody/incarcerated. * Patients unable to communicate in either Spanish or English.

Design outcomes

Primary

MeasureTime frame
Hospital length of stayfrom time of admission to time of discharge (about 3 days from date of surgery)

Secondary

MeasureTime frameDescription
Number of participants that require reoperationUpto 1 year after surgery
Time to total wound healingFrom end of surgery to upto 1 year after surgery
Number of participants that need skin graftUpto 1 year after surgery
time from original surgery with placement of wound vac until the patient gets a skin graftupto 1 year after surgery
Number of participants that have recurrent surgical site infectionUpto 1 year after surgery
Number of participants that need wound vac after dischargeAt discharge (about 3 days from date of surgery)
Inpatient hospital costsAt discharge (about 3 days from date of surgery)
financial toxicity experienced by patients as assessed by the COST - FACIT survey3 months after dischargeThis is a 12 item questionnaire and each is scored from 0( not at all) to 4(very much), for a maximum score of 48, higher score indicating lower financial toxicity.
financial toxicity experienced by patients as assessed by the COmprehensive Score for financial Toxicity (COST)-Functional Assessment of Chronic Illness Therapy (FACIT) survey12 months after dischargeThis is a 12 item questionnaire and each is scored from 0( not at all) to 4(very much). Questions 2,3,6 and 7 are reverse scored for a maximum score of 48, higher score indicating lower financial toxicity.
time to return to workFrom discharge (about 3 days from date of surgery) upto 1 year after surgery

Countries

United States

Contacts

Primary ContactJonah Stulberg, MD
Jonah.J.Stulberg@uth.tmc.edu(713) 566-5098
Backup ContactDebbie Lew
Debbie.F.Lew@uth.tmc.edu713-566-5097

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026